Complications associated with neoadjuvant radiotherapy in the multidisciplinary treatment of retroperitoneal sarcomas

被引:27
作者
Caudle, Abigail S.
Tepper, Joel E.
Calvo, Benjamin F.
Meyers, Michael O.
Goyal, Lav K.
Cance, William G.
Kim, Hong Jin
机构
[1] Univ N Carolina, Sch Med, Dept Surg, Div Surg Oncol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA
[3] Univ Florida, Dept Surg, Gainesville, FL 32610 USA
关键词
retroperitoneal sarcoma; radiotherapy; complications;
D O I
10.1245/s10434-006-9248-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Retroperitoneal sarcomas (RPS) remain a therapeutic challenge due to high local recurrence rates. Preoperative RT offers theoretical advantages in the multidisciplinary care of RPS. The purpose of our study was to evaluate our experience using preoperative radiotherapy (PRT) in the treatment of RPS. Methods: This is a single-institution review of patients with RPS treated with PRT from 1994 until 2004. Three radiation oncologists and four surgical oncologists were involved. Medical records, tumor registries, and death records were reviewed. Results: Fourteen patients were included; nine were treated for primary presentation and five for recurrent disease. Histologic grade was grade I (n = 3), grade II (n = 3), and grade III (n = 8). Five patients received additional IORT. Radiotherapy complications were generally mild, including nausea (n = 3), diarrhea (n = 1), dehydration (n = 1), anemia (n = 1), and skin changes (n = 1); one required early cessation due to nausea. Thirteen patients had gross negative margins; while 7/13 had negative microscopic margins. Operative complications included anastomotic bleeding (n = 1), fluid collections (n = 2), ileus (n = 3), ascites (n = 2), temporary leg weakness (n = 1), and uncomplicated wound infections (n = 2). In patients with R0 or R1 resections, one and two year local control rates were 64 and 50%. Overall survival for all patients was 90% at 1 year and 74% at 2 years with median survival of 21 months. Conclusion: PRT and IORT can be administered effectively in carefully selected patients with resectable RPS. Larger multi-center studies are needed to delineate the role of PRT and IORT to improve local recurrence and survival rates in the treatment of RPS.
引用
收藏
页码:577 / 582
页数:6
相关论文
共 27 条
[1]   Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy [J].
Cheng, TY ;
Sheth, K ;
White, RR ;
Ueno, T ;
Hung, CF ;
Clary, BM ;
Pappas, TN ;
Tyler, DS .
ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (01) :66-74
[2]  
Chessin DB, 2005, J AM COLL SURGEONS, V200, P876, DOI 10.1016/j.jamcollsurg.2005.02.027
[3]  
EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335
[4]   Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma [J].
Gieschen, HL ;
Spiro, IJ ;
Suit, HD ;
Ott, MJ ;
Rattner, DW ;
Ancukiewicz, M ;
Willett, CG .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (01) :127-131
[5]   Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma [J].
Gilbeau, L ;
Kantor, G ;
Stoeckle, E ;
Lagarde, P ;
Thomas, L ;
Kind, M ;
Richaud, P ;
Coindre, JM ;
Bonichon, F ;
Bui, BN .
RADIOTHERAPY AND ONCOLOGY, 2002, 65 (03) :137-143
[6]  
HELSIN M, 1997, J CLIN ONCOL, V15, P1832
[7]   Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma [J].
Jones, JJ ;
Catton, CN ;
O'Sullivan, B ;
Couture, J ;
Heisler, RL ;
Kandel, RA ;
Swallow, CJ .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (04) :346-354
[8]  
KREMPIEN R, 2006, INT J RAD ONCOL BIOL
[9]   Retroperitoneal soft-tissue sarcoma - Analysis of 500 patients treated and followed at a single institution [J].
Lewis, JJ ;
Leung, D ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 1998, 228 (03) :355-363
[10]   Influence of biologic factors and anatomic site in completely resected liposarcoma [J].
Linehan, DC ;
Lewis, JJ ;
Leung, D ;
Brennan, MF .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) :1637-1643